CTNNB1 and hepatocellular carcinoma: We did not identify any mutations in CTNNB1 in any of three HCC tumors in this study, however we did identify recurrent nonsynonymous mutations in two genes involved in the Wnt/β-catenin signaling pathway: AXIN2 and MED12.